Recommendations

Spirometry should be carried out for the effective study of COPD.

Other lung functions measurements should be dependent on the COPD study.

Spirometry is perhaps the most effective and widely used method for diagnosing COPD.

It is a simple, painless test that assesses lung ability and function. According to recent data

published in the Annals of the American Thoracic Society, the prevalence of undiagnosed COPD

was high among a sample of people who took part in low-dose CT lung cancer screening,

implying that adding spirometry to radiological results would certainly increase COPD detection.

According to the data, more than half of those who go for lung health examination as part of a

prescreening evaluation find pathological criteria of airflow obstruction associated with a

diagnosis of COPD. Spirometry-detected physiological improvements in airway obstruction are

the best indicator of the presence of respiratory symptoms, making them potentially clinically

important in COPD study.

Other lung function tests should be performed based on the study's basic objectives. The

tests should be carried out according to the latest ATS/ERS guidelines since COPD is staged

based on airflow limits measured in FEV percentage. According to clinical guidelines, the

significance of this is that ATS/ERS classifies the magnitude of airflow limits.

Continuation

The effectiveness of inhaled therapies should be assessed.

Assessment of inhaled corticosteroid responsiveness

 In people with healthy COPD and asthma, there is a need to study the therapeutic and

cost-efficacy of inhaled treatments such as bronchodilators and inhaled corticosteroids. Several

studies look at the efficacy of bronchodilators and hormones in patients with COPD, but the bulk

of them exclude people who already have asthma. As a result, there is a lack of evidence

regarding the most clinically and economically effective for COPD patients' treatments. People

with asthma and COPD should be enrolled in trials to provide this evidence and receive the most

effective COPD and asthma maintenance treatments.

There is a need to determine the traits that more reliably predict inhaled corticosteroid

response in COPD patients. This is significant since bronchodilators and steroids are the most

common pharmacological therapies for COPD. For the most successful treatment of their

symptoms, people with asthma or asthmatic characteristics may make them steroid prone that

they may need a different combination of medications than other classes of patients with COPD.

Identifying these individuals would assist in ensuring that they receive the medication they need.